SCHEMBL15570666

SCHEMBL15570666

NS(=O)(=O)C(CCO)n1ccnc1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.45
CA1 P00915 5/20 0.45
CA2 P00918 5/20 0.45
CA9 Q16790 5/20 0.45
LMNA P02545 1/20 0.44
THRB P10828 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.38
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
OPRK1 P41145 1/20 0.33
TYMP P19971 3/20 0.33
CCR10 P46092 2/20 0.32
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15570602 0.83 CA1 (0.42) CA12CA1CA2CA9LMNA
SCHEMBL15570179 0.83 CA1 (0.42) CA12CA1CA2CA9LMNA
SCHEMBL15569511 0.77 CYP3A4 (0.44) CA12CA1CA2CA9LMNA
SCHEMBL296106 0.74 LMNA (0.48) CA12CA1CA2CA9LMNA
SCHEMBL15570357 0.72 MAPK1 (0.35) CA12CA1CA2CA9LMNA
SCHEMBL6275195 0.72 LMNA (0.41) CA12CA1CA2CA9LMNA
SCHEMBL15570480 0.69 L3MBTL1 (0.35) LMNAKMT2AATM
SCHEMBL28818918 0.69 KMT2A (0.48) CA12CA1CA2CA9LMNA
SCHEMBL2360743 0.69 KMT2A (0.43) CA12CA1CA2CA9LMNA
SCHEMBL27795012 0.68 KMT2A (0.44) CA12CA1CA2CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014030142-A2 NITROIMIDAZOLE COMPOUNDS AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2014-02-27 WO claimed
WO-2014030142-A2 NITROIMIDAZOLE COMPOUNDS AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2014-02-27 WO disclosed